Skip to main content
All lobbying filings

AMERICAN SOCIETY OF NEPHROLOGY

Lobbying for AMERICAN SOCIETY OF NEPHROLOGY

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $90,000.00 expenses · posted Apr 15, 2025

Official filing document

 Bills named in this filing 5
  • HR 628
    Honor Our Living Donors Act
  • S 957
    Honor Our Living Donors Act
  • S 532
    OPTN Fee Collection Authority Act
  • S 1261
    CONNECT for Health Act of 2025
  • HR 879
    Medicare Patient Access and Practice Stabilization Act of 2025
 Lobbying activity 2
Health Issues

-Honor Our Living Donors Act (H.R. 628 / S. 957) Legislation to simplify the process of determining eligibility for reimbursement for living kidney donation-related costs -OPTN Fee Collection Authority Act (S. 532) Legislation to clarify HRSA and HHS' ability to collect and distribute OPTN patient waitlist registration fees to support ongoing operation of the US transplant system -Expanding Support for Living Donors Act (draft bill) Draft legislation to expand eligibility for living kidney donors to receive reimbursement for living kidney donation-related costs -CONNECT for Health Act (S. 1261) Legislation to expand the use of telehealth and remote patient monitoring services in Medicare on a permanent basis -Medicare Patient Access and Practice Stabilization Act of 2025 (H.R. 879) Legislation to reverse a recent cut to physicians and other health professionals in the Medicare program and to provide stability in Medicare physician payments moving forward -$67M in appropriations for HRSA Organ Transplant work in FY26 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY26 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged CMS to ensure kidney health data, particularly through the EQRS, remains readily available to the kidney research community as well as to the USRDS

Science/Technology

-$51.303B in appropriations for NIH in FY26 (to support investments in basic, clinical, translational, and other health-related research activities) -$25M in appropriations for HHS in FY26 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions)

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem